Cisplatin as Single-Agent Chemotherapy in Patients with Liver Dysfunction Due to Metastases

Publisher： Karger

E-ISSN： 2296-5262|32|7|400-404

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.7, 2009-06, pp. : 400-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single-Agent Chemotherapy with Docetaxel Significantly Reduces PSA Levels in Patients with High-Grade Localized Prostate Cancers

By  

Urologia Internationalis, Vol. 73, Iss. 2, 2004-08 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 783-789

Karger

Access to resources Recommend Favorite

Resistance to single‐agent chemotherapy and its risk factors in low‐risk gestational trophoblastic neoplasms

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 5, 2015-05 ,pp. : 776-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 291-295

Karger

Access to resources Recommend Favorite

Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 637-643

Karger

Access to resources Recommend Favorite